ResMed Inc. (RMD) Presents at forty sixth Annual William Blair Growth Stock Conference Prepared Remarks Transcript

Brandon Vazquez
William Blair & Company L.L.C., Research Division

Hello, everybody. My name is Brandon Vazquez. For those of you who I haven’t met before, I’m 1 of William Blair’s medical device analyst, also cover animal health for the firm. I am required to inform you for a complete list of research disclosures and potential conflicts of interest go to williamblair.com.

And with that, I am happy to say that we have the ResMed team here. We have Mick Farrell, the CEO; and Aaron Bloomer, the new CFO. Happy to join us here. They’re going to give us a corporate presentation as many of the — as we’ve been doing all day. We will actually stay in this room for the breakout session, so at the end, I’ll come up here. I might give us like 5 minutes to let people trickle in if they’re coming from another session. And then we’ll do Q&A here.

With that, I’ll turn it over to Mike.

Michael Farrell
CEO & Chairman

Excellent. Well, thanks. And I’ve got the time here, so I’ll stick pretty closely to the 29 minutes they got me here on the presentation. Look forward to a lot of questions and a good discussion around sleep health, breathing health and the health care technology delivered at home.

Forward-looking statements, you can read on your own.

Yes, ResMed is the global leader in the field of connected health and digital health. We have over 26 billion nights of medical data in the cloud. Over 30 million 100% cloud connectable medical devices sold in over 144 countries